KRAS and lung cancer: Overall, these data from human lung cancer samples that have not been treated with KRAS inhibitory drugs suggest that cellular communities similar to the mouse T/DC community exist at baseline, where CD4+and CD8+ T cells, DCs, and Tregs were gathered together at the tumor periphery.